Beduneau et al. Intensive Care Medicine Experimental 2015, 3(Suppl 1):A426
http://www.icm-experimental.com/content/3/S1/A426
POSTER PRESENTATION Open Access
Prognosis of mechanically ventilated patients entering the weaning process
G Beduneau1*, T Pham2*, JCM Richard3, F Schortgen4, JM Chretien5, A Mercat6, J Mancebo7, L Brochard8,
WIND Study Group on behalf of REVA Network From ESICM LIVES 2015
Berlin, Germany. 3-7 October 2015
Introduction
The WIND study Weaning according to New Definition prospectively collected epidemiologic data concerning mechanical ventilation (MV) and weaning. The aim of the present analysis was to specifically address mortality at the different pre-defined steps of the weaning process.
Methods
This is a subsequent analysis of the original prospective observational study run in 36 intensive care units in France, Spain and Switzerland over a three month period. All patients requiring intubation and MV were enrolled. MV modality, results of spontaneous breathing trials (SBT) and extubation, therapeutic limitation as well as survival were daily collected until ICU discharge or day 60. A weaning attempt (WA) was defined either by a spontaneous breathing trial or a direct extubation (planned or unplanned). Weaning success was defined as discharged alive without mechanical ventilation within the 7 days following extubation. The prognosis of patients at the key steps of the weaning process was analysed as mortality at ICU discharge or D60.
Results
2729 patients were enrolled and 20 specifically intubated for upper airway obstacle were excluded. 2709 patients
were analysed among whom 2051 entered the weaning process (i.e. had at least one WA). Prognosis is reported on table 1 for the whole cohort, for the patients entering weaning, after failure of the first WA and for the patients still ventilated 7 days after the first WA.
Conclusions
Based on this large cohort of intubated patients, mortality was 10% for the patients entering the weaning process but was three times higher (33%) in patients failing their 1st
WA; 63% of the deaths occurred within one week after the failed WA. The present analysis is the first to document mortality along different steps of the weaning process as experienced in daily practice.
Grant Acknowledgment
Association daide aux insuffisants respiratoires (Rouen, France)
*GB and TP are considered both as first authors.
Authors details
1University Hospital, Rouen, France. 2Medical and Surgical Intensive Care, Hpital Tenon, APHP, Paris, France. 3Annecy Genevois General Hospital, Annecy, France. 4Medical ICU, CHU Henri Mondor, APHP Paris, Paris, France.
5Clinical Research Institute Angers Universitary Hospital, Angers, France.
6Medical Intensive Care, Universitary Hospital Angers, Angers, France.
7Hospital de Sant Pau, Barcelona, Spain, Barcelona, Spain. 8Saint Michaels
Table 1. After failure of 1st WA, 125 patients (among the 197 dead) died in the seven first days
Intubated patients Entering weaning (WA) Failure 1st WA Still ventilated 7 days after 1st WA Patients (N) 2709 2051 605 218Mortality, % (N) 28 (771) 10 (205) 33 (197) 28 (62)
1University Hospital, Rouen, France
2Medical and Surgical Intensive Care, Hpital Tenon, APHP, Paris, France Full list of author information is available at the end of the article
2015 Beduneau et al.; This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0
Web End =http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Beduneau et al. Intensive Care Medicine Experimental 2015, 3(Suppl 1):A426
http://www.icm-experimental.com/content/3/S1/A426
Page 2 of 2
Hospital and Keenan Research Centre, Interdepartmental Division of Critical Care, University of Toronto, Toronto, Canada.
Published: 1 October 2015
doi:10.1186/2197-425X-3-S1-A426Cite this article as: Beduneau et al.: Prognosis of mechanically ventilated patients entering the weaning process. Intensive Care Medicine Experimental 2015 3(Suppl 1):A426.
Submit your manuscript to a
journal and benet from:
7 Convenient online submission7 Rigorous peer review7 Immediate publication on acceptance7 Open access: articles freely available onlihttp://www.springeropen.com/
Web End =ne 7 High visibility within the eld7 Retaining the copyright to your article
Submit your next manuscript at 7 http://www.springeropen.com/
Web End =springeropen.com
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
The Author(s) 2015
Abstract
Issue Title: ESICM LIVES 2015
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer